Metropolis Healthcare Limited

Equities

METROPOLIS

INE112L01020

End-of-day quote NSE India S.E. Other stock markets 2026-01-14			5-day change	1st Jan Change
1,884.50 ^INR	-1.17%		-5.23%	-2.30%

Jan. 04	Metropolis Health standalone revenue growth at 15% YoY	RE
Nov. 06	Metropolis Healthcare Limited, Q2 2026 Earnings Call, Nov 06, 2025

Transcript : Metropolis Healthcare Limited, Q2 2026 Earnings Call, Nov 06, 2025

Published on 11/06/2025 at 06:20 am EST - Modified on 12/08/2025 at 01:11 pm EST

S&P Capital IQ

Presentation Operator Message
Operator (Operator)

Ladies and gentlemen, good day, and welcome to the Q2 and H1 FY '26 Earnings Conference Call of Metropolis Healthcare Limited, hosted by BNP Paribas.

This article is reserved for subscribers

Unlock the article : SUBSCRIBE!

Already a customer? Log In

Latest news about Metropolis Healthcare Limited

Jan. 04	Metropolis Health standalone revenue growth at 15% YoY	RE
Nov. 06	Metropolis Healthcare Limited, Q2 2026 Earnings Call, Nov 06, 2025
Nov. 04	Metropolis Healthcare Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2025	CI
Nov. 04	Metropolis Healthcare Limited Approves a Dividend	CI
25-10-07	Financials lead Indian equity benchmarks higher for fourth session	RE
25-09-19	Metropolis Healthcare Completes Acquisition of Ambika Pathology Laboratory in Kolhapur; Shares up 3%	MT
25-09-18	Metropolis Healthcare buys Ambika Pathology Laboratory	RE
25-09-17	Metropolis Healthcare Limited completed the acquisition of Ambika Pathology Laboratory from Rajendra Sadashiv Patil.	CI
25-09-16	Metropolis Healthcare Incorporates Wholly-Owned Subsidiary	MT
25-09-16	Metropolis Healthcare Limited Incorporates Wholly Owned Subsidiary Metropolis Quality Solutions Private Limited	CI
25-08-08	Metropolis Healthcare Limited, Q1 2026 Earnings Call, Aug 08, 2025
25-08-07	Metropolis Healthcare Limited Reports Earnings Results for the First Quarter Ended June 30, 2025	CI
25-08-06	Metropolis Healthcare Limited entered into a business transfer agreement to acquire Ambika Pathology Laboratory from Rajendra Sadashiv Patil for INR 170 million.	CI
25-07-18	Metropolis Healthcare says Sushil Shah steps down as chairman emeritus	RE
25-07-11	Indian Indices Extend Losses on Profit-Taking, Global Trade Tensions	MT
25-07-10	Indian Shares Slump Despite Potential US Trade Talks	MT
25-07-09	Indian Stocks Dip Over Trump's Announcement of Copper Tariffs	MT
25-07-04	Metropolis Healthcare says Q1FY26 revenue growth approx. 23% y-o-y	RE
25-06-18	Metropolis Healthcare Limited Appoints Dr. Monika Prabhakar as "Group Head Lab Operations" Effective from June 19, 2025	CI
25-06-17	Metropolis Healthcare Unit Acquires Scientific Pathology Business	MT
25-06-17	Metropolis Healthcare Says Subsidiary Buys Dr. Ashok Kumar Sharma's Scientific Pathology	RE
25-06-01	Metropolis Healthcare Extends Timeline for Scientific Pathology Acquisition by 15 Days	MT
25-05-14	Metropolis Healthcare Limited, Q4 2025 Earnings Call, May 14, 2025
25-05-13	Metropolis Healthcare Limited Reports Earnings Results for the Full Year Ended March 31, 2025	CI
25-05-13	Metropolis Healthcare Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2025	CI